ArticleBMJ open2023

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial.

Maxime Desmarets et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.